The effect of diabetes mellitus on osseous healing

Clinical Oral Implants Research

Volumn 21, Issue 7, 2010, Pages 673-681

  Retzepi, M ^a   Donos, N ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bone healing; Diabetes mellitus; Hyperglycaemia; Insulin; Ossification

Indexed keywords

INSULIN; TOOTH IMPLANT;

ANIMAL; BONE REGENERATION; DIABETES MELLITUS; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; FRACTURE HEALING; HUMAN; HYPERCALCIURIA; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; TOOTH IMPLANTATION; DRUG EFFECTS; TOOTH IMPLANT;

ANIMALS; DENTAL IMPLANTS; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FRACTURE HEALING; HUMANS; HYPERCALCIURIA; HYPERGLYCEMIA; INSULIN; OSSEOINTEGRATION; OSTEOPOROSIS;

EID: 77954605645     PISSN: 09057161     EISSN: 16000501     Source Type: Journal    
DOI: 10.1111/j.1600-0501.2010.01923.x     Document Type: Review

References (108)

1. Accursi GE. 2000, Treatment outcomes with osseointegrated Brånemark implants in diabetic patients: a retrospective study. Thesis, University of Toronto, Toronto, ON
2. Ahmad T, Ugarph-Morawski A, Li J, Bileviciute-Ljungar I, Finn A, Ostenson CG, Kreicbergs A. Bone and joint neuropathy in rats with type-2 diabetes. Regulatory Peptides 2004, 119:61-67.
3. Alrefai H, Allababidi H, Levy S, Levy J. The endocrine system in diabetes mellitus. Endocrine 2002, 18:105-119.
4. Amir G, Rosenmann E, Sherman Y, Greenfeld Z, Ne'eman Z, Cohen AM. Osteoporosis in the Cohen diabetic rat: correlation between histomorphometric changes in bone and microangiopathy. Laboratory Investigation 2002, 82:1399-1405.
5. Balint E, Szabo P, Marshall CF, Sprague SM. Glucose-induced inhibition of in vitro bone mineralization. Bone 2001, 28:21-28.
6. Beam HA, Parsons JR, Lin SS. The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitus. Journal of Orthopaedic Research 2002, 20:1210-1216.
7. Bibbo C, Lin SS, Beam HA, Behrens FF. Complications of ankle fractures in diabetic patients. The Orthopedic Clinics of North America 2001, 32:113-133.
8. Bjurholm A, Kreicbergs A, Schultzberg M, Lerner UH. Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells. Journal of Bone and Mineral Research 1992, 7:1011-1019.
9. Botolin S, Faugere MC, Malluche H, Orth M, Meyer R, McCabe LR. Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice. Endocrinology 2005, 146:3622-3631.
10. Botolin S, McCabe LR. Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. Journal of Cellular Biochemistry 2006, 99:411-424.
11. Botolin S, McCabe LR. Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology 2007, 148:198-205.
12. Bouillon R. Diabetic bone disease. Calcified Tissue International 1991, 49:155-160.
13. Canalis E. Effect of hormones and growth factors on alkaline phosphatase activity and collagen synthesis in cultured rat calvariae. Metabolism 1983, 32:14-20.
14. Carnevale V, Romagnoli E, D'Erasmo E. Skeletal involvement in patients with diabetes mellitus. Diabetes/Metabolism Research and Reviews 2004, 20:196-204.
15. Cloos C, Wahl P, Hasslacher C, Traber L, Kistner M, Jurkuhn K, Schmidt-Gayk H. Urinary glycosylated, free and total pyridinoline and free and total deoxypyridinoline in diabetes mellitus. Clinical Endocrinology 1998, 48:317-323.
16. Conover CA, Lee PD, Riggs BL, Powell DR. Insulin-like growth factor-binding protein-1 expression in cultured human bone cells: regulation by insulin and glucocorticoid. Endocrinology 1996, 137:3295-3301.
17. Cornish J, Callon KE, Reid IR. Insulin increases histomorphometric indices of bone formation in vivo. Calcified Tissue International 1996, 59:492-495.
18. Cozen L. Does diabetes delay fracture healing? Clinical Orthopaedics and Related Research 1972, 82:134-140.
19. Craig RG, Rowe DW, Petersen DN, Kream BE. Insulin increases the steady state level of alpha-1(I) procollagen mRNA in the osteoblast-rich segment of fetal rat calvaria. Endocrinology 1989, 125:1430-1437.
20. Dixit PK, Ekstrom RA. Decreased breaking strength of diabetic rat bone and its improvement by insulin treatment. Calcified Tissue International 1980, 32:195-199.
21. Einhorn TA, Boskey AL, Gundberg CM, Vigorita VJ, Devlin VJ, Beyer MM. The mineral and mechanical properties of bone in chronic experimental diabetes. Journal of Orthopaedic Research 1988, 6:317-323.
22. Fiorellini JP, Chen PK, Nevins M, Nevins ML. A retrospective study of dental implants in diabetic patients. International Journal of Periodontics and Restorative Dentistry 2000, 20:366-373.
23. Fiorellini JP, Nevins ML, Norkin A, Weber HP, Karimbux NY. The effect of insulin therapy on osseointegration in a diabetic rat model. Clinical Oral Implants Research 1999, 10:362-368.
24. Folk JW, Starr AJ, Early JS. Early wound complications of operative treatment of calcaneus fractures: analysis of 190 fractures. Journal of Orthopaedic Trauma 1999, 13:369-372.
25. Follak N, Kloting I, Merk H. Influence of diabetic metabolic state on fracture heating in spontaneously diabetic rats. Diabetes-Metabolism Research and Reviews 2005, 21:288-296.
26. Follak N, Kloting I, Wolf E, Merk H. Histomorphometric evaluation of the influence of the diabetic metabolic state on bone defect healing depending on the defect size in spontaneously diabetic BB/OK rats. Bone 2004a, 35:144-152.
27. Follak N, Kloting I, Wolf E, Merk H. Improving metabolic control reverses the histomorphometric and biomechanical abnormalities of an experimentally induced bone defect in spontaneously diabetic rats. Calcified Tissue International 2004b, 74:551-560.
28. Fowlkes JL, Bunn RC, Liu L, Wahl EC, Coleman HN, Cockrell GE, Perrien DS, Lumpkin CK, Thrailkill KM. Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus. Endocrinology 2008, 149:1697-1704.
29. Funk JR, Hale JE, Carmines D, Gooch HL, Hurwitz SR. Biomechanical evaluation of early fracture healing in normal and diabetic rats. Journal of Orthopaedic Research 2000, 18:126-132.
30. Gandhi A, Beam HA, O'Connor JP, Parsons JR, Lin SS. The effects of local insulin delivery on diabetic fracture healing. Bone 2005, 37:482-490.
31. Gebauer GP, Lin SS, Beam HA, Vieira P, Parsons JR. Low-intensity pulsed ultrasound increases the fracture callus strength in diabetic BB Wistar rats but does not affect cellular proliferation. Journal of Orthopaedic Research 2002, 20:587-592.
32. Gerritsen M, Lutterman JA, Jansen JA. Wound healing around bone-anchored percutaneous devices in experimental diabetes mellitus. Journal of Biomedical Materials Research 2000, 53:702-709.
33. Giglio MJ, Giannunzio G, Olmedo D, Guglielmotti MB. Histomorphometric study of bone healing around laminar implants in experimental diabetes. Implant Dentistry 2000, 9:143-149.
34. Gooch HL, Hale JE, Fujioka H, Balian G, Hurwitz SR. Alterations of cartilage and collagen expression during fracture healing in experimental diabetes. Connective Tissue Research 2000, 41:81-91.
35. Goodman WG, Hori MT. Diminished bone formation in experimental diabetes. Relationship to osteoid maturation and mineralization. Diabetes 1984, 33:825-831.
36. Gunczler P, Lanes R, Paz-Martinez V, Martins R, Esaa S, Colmenares V, Weisinger JR. Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally. Journal of Pediatric Endocrinology and Metabolism 1998, 11:413-419.
37. Haffner SM, Bauer RL. The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal women. Metabolism 1993, 42:735-738.
38. Hahn TJ, Westbrook SL, Sullivan TL, Goodman WG, Halstead LR. Glucose transport in osteoblast-enriched bone explants: characterization and insulin regulation. Journal of Bone and Mineral Research 1988, 3:359-365.
39. Hashizume M, Yamaguchi M. Stimulatory effect of beta-alanyl-l-histidinato zinc on cell proliferation is dependent on protein synthesis in osteoblastic MC3T3-E1 cells. Molecular and Cellular Biochemistry 1993, 122:59-64.
40. Heap J, Murray MA, Miller SC, Jalili T, Moyer-Mileur LJ. Alterations in bone characteristics associated with glycemic control in adolescents with type 1 diabetes mellitus. The Journal of Pediatrics 2004, 144:56-62.
41. Herbsman H, Powers JC, Hirschman A, Shaftan GW. Retardation of fracture healing in experimental diabetes. The Journal of Surgical Research 1968, 8:424-431.
42. Hie M, Shimono M, Fujii K, Tsukamoto I. Increased cathepsin K and tartrateresistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats. Bone 2007, 41:1045-1050.
43. Horcajada-Molteni MN, Chanteranne B, Lebecque P, Davicco MJ, Coxam V, Young A, Barlet JP. Amylin and bone metabolism in streptozotocin-induced diabetic rats. Journal of Bone and Mineral Research 2001, 16:958-965.
44. Hou JC, Zernicke RF, Barnard RJ. Experimental diabetes, insulin treatment, and femoral neck morphology and biomechanics in rats. Clinical Orthopaedics and Related Research 1991, 264:278-285.
45. Hou JC, Zernicke RF, Barnard RJ. Effects of severe diabetes and insulin on the femoral neck of the immature rat. Journal of Orthopaedic Research 1993, 11:263-271.
46. Hough S, Avioli LV, Teitelbaum SL, Fallon MD. Alkaline phosphatase activity in chronic streptozotocin-induced insulin deficiency in the rat: effect of insulin replacement. Metabolism 1981, 30:1190-1194.
47. Ituarte EA, Halstead LR, Iida-Klein A, Ituarte HG, Hahn TJ. Glucose transport system in UMR-106-01 osteoblastic osteosarcoma cells: regulation by insulin. Calcified Tissue International 1989, 45:27-33.
48. Iyama S, Takeshita F, Ayukawa Y, Kido MA, Suetsugu T, Tanaka T. A study of the regional distribution of bone formed around hydroxyapatite implants in the tibiae of streptozotocin-induced diabetic rats using multiple fluorescent labeling and confocal laser scanning microscopy. Journal of Periodontology 1997, 68:1169-1175.
49. Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. American Journal of Epidemiology 2007, 166:495-505.
50. Kawaguchi H, Kurokawa T, Hanada K, Hiyama Y, Tamura M, Ogata E, Matsumoto T. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 1994, 135:774-781.
51. Kemink SA, Hermus AR, Swinkels LM, Lutterman JA, Smals AG. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. Journal of Endocrinological Investigation 2000, 23:295-303.
52. Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Du YS, Hofmann M, Yan SF, Pischetsrieder M, Stern D, Schmidt AM. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. The Journal of Biological Chemistry 1999, 274:31740-31749.
53. Krakauer JC, McKenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM. Bone loss and bone turnover in diabetes. Diabetes 1995, 44:775-782.
54. Kume S, Kato S, Yamagishi S, Inagaki Y, Ueda S, Arima N, Okawa T, Kojiro M, Nagata K. Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. Journal of Bone and Mineral Research 2005, 20:1647-1658.
55. Lalla E, Lamster IB, Schmidt AM. Enhanced interaction of advanced glycation end products with their cellular receptor RAGE: implications for the pathogenesis of accelerated periodontal disease in diabetes. Annals of Periodontology 1998, 3:13-19.
56. Laroche M. Intraosseous circulation from physiology to disease. Joint Bone Spine 2002, 69:262-269.
57. Lerner UH. Neuropeptidergic regulation of bone resorption and bone formation. Journal of Musculoskeletal and Neuronal Interactions 2002, 2:440-447.
58. Lettgen B, Hauffa B, Mohlmann C, Jeken C, Reiners C. Bone mineral density in children and adolescents with juvenile diabetes: selective measurement of bone mineral density of trabecular and cortical bone using peripheral quantitative computed tomography. Hormone Research 1995, 43:173-175.
59. Loder RT. The influence of diabetes mellitus on the healing of closed fractures. Clinical Orthopaedics and Related Research 1988, 232:210-216.
60. Lu H, Kraut D, Gerstenfeld LC, Graves DT. Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. Endocrinology 2003, 144:346-352.
61. Macey LR, Kana SM, Jingushi S, Terek RM, Borretos J, Bolander ME. Defects of early fracture-healing in experimental diabetes. The Journal of Bone and Joint Surgery. American volume 1989, 71:722-733.
62. Margonar R, Sakakura CE, Holzhausen M, Pepato MT, Alba RC, Marcantonio E. The influence of diabetes mellitus and insulin therapy on biomechanical retention around dental implants: a study in rabbits. Implant Dentistry 2003, 12:333-339.
63. Mathiassen B, Nielsen S, Ditzel J, Rodbro P. Long-term bone loss in insulin dependent diabetes mellitus. Journal of Internal Medicine 1990, 227:325-327.
64. McCabe LR. Understanding the pathology and mechanisms of type I diabetic bone loss. Journal of Cellular Biochemistry 2007, 102:1343-1357.
65. McCarthy AD, Etcheverry SB, Bruzzone L, Lettieri G, Barrio DA, Cortizo AM. Non-enzymatic glycosylation of a type I collagen matrix: effects on osteoblastic development and oxidative stress. BMC Cell Biology 2001, 2:16.
66. McCarthy AD, Uemura T, Etcheverry SB, Cortizo AM. Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix. The International Journal of Biochemistry and Cell Biology 2004, 36:840-848.
67. McCracken M, Lemons JE, Rahemtulla F, Prince CW, Feldman D. Bone response to titanium alloy implants placed in diabetic rats. The International Journal of Oral & Maxillofacial Implants 2000, 15:345-354.
68. Mombelli A, Cionca N. Systemic diseases affecting osseointegration therapy. Clinical Oral Implants Research 2006, 17((Suppl. 2)):97-103.
69. Morris HF, Ochi S, Winkler S. Implant survival in patients with type 2 diabetes: placement to 36 months. Annals of Periodontology 2000, 5:157-165.
70. Moy PK, Medina D, Shetty V, Aghaloo TL. Dental implant failure rates and associated risk factors. The International Journal of Oral & Maxillofacial Implants 2005, 20:569-577.
71. Nevins ML, Karimbux NY, Weber HP, Giannobile WV, Fiorellini JP. Wound healing around endosseous implants in experimental diabetes. The International Journal of Oral & Maxillofacial Implants 1998, 13:620-629.
72. Olmos JM, Perez-Castrillon JL, Garcia MT, Garrido JC, Amado JA, Gonzalez-Macias J. Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus. Bone and Mineral 1994, 26:1-8.
73. Ottoni CE, Chopard RP. Histomorphometric evaluation of new bone formation in diabetic rats submitted to insertion of temporary implants. Brazilian Dental Journal 2004, 15:87-92.
74. Papa J, Myerson M, Girard P. Salvage, with arthrodesis, in intractable diabetic neuropathic arthropathy of the foot and ankle. The Journal of Bone and Joint Surgery. American volume 1993, 75:1056-1066.
75. Pedrazzoni M, Ciotti G, Pioli G, Girasole G, Davoli L, Palummeri E, Passeri M. Osteocalcin levels in diabetic subjects. Calcified Tissue International 1989, 45:331-336.
76. Piepkorn B, Kann P, Forst T, Andreas J, Pfutzner A, Beyer J. Bone mineral density and bone metabolism in diabetes mellitus. Hormone and Metabolic Research 1997, 29:584-591.
77. Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002, 45:1085-1096.
78. Retzepi M. 2009, The effect of experimental diabetes on Guided Bone Regeneration. PhD thesis, Eastman Dental Institute, University College London
79. Retzepi M, Lewis MP, Donos N. Effect of diabetes and metabolic control on de novo bone formation following Guided Bone Regeneration. Clinical Oral Implants Research 2010, 21:71-79.
80. Rix M, Andreassen H, Eskildsen P. Impact of peripheral neuropathy on bone density in patients with type 1 diabetes. Diabetes Care 1999, 22:827-831.
81. Saito M, Fujii K, Mori Y, Marumo K. Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporosis International 2006, 17:1514-1523.
82. Salerno M, Argenziano A, Di Maio S, Gasparini N, Formicola S, De Filippo G, Tenore A. Pubertal growth, sexual maturation, and final height in children with IDDM. Effects of age at onset and metabolic control. Diabetes Care 1997, 20:721-724.
83. Santana RB, Trackman PC. Controlled release of fibroblast growth factor 2 stimulates bone healing in an animal model of diabetes mellitus. The International Journal of Oral & Maxillofacial Implants 2006, 21:711-718.
84. Santana RB, Xu L, Chase HB, Amar S, Graves DT, Trackman PC. A role for advanced glycation end products in diminished bone healing in type 1 diabetes. Diabetes 2003, 52:1502-1510.
85. Schwartz AV. Diabetes mellitus: does it affect bone? Calcified Tissue International 2003, 73:515-519.
86. Shernoff AF, Colwell JA, Bingham SF. Implants for type II diabetic patients: interim report. VA implants in diabetes study group. Implant Dentistry 1994, 3:183-185.
87. Shires R, Teitelbaum SL, Bergfeld MA, Fallon MD, Slatopolsky E, Avioli LV. The effect of streptozotocin-induced chronic diabetes mellitus on bone and mineral homeostasis in the rat. The Journal of Laboratory and Clinical Medicine 1981, 97:231-240.
88. Siqueira JT, Cavalher-Machado SC, Arana-Chavez VE, Sannomiya P. Bone formation around titanium implants in the rat tibia: role of insulin. Implant Dentistry 2003, 12:242-251.
89. Smith RA, Berger R, Dodson TB. Risk factors associated with dental implants in healthy and medically compromised patients. The International Journal of Oral & Maxillofacial Implants 1992, 7:367-372.
90. Spanheimer RG, Umpierrez GE, Stumpf V. Decreased collagen production in diabetic rats. Diabetes 1988, 37:371-376.
91. Stuart MJ, Morrey BF. Arthrodesis of the diabetic neuropathic ankle joint. Clinical Orthopaedics and Related Research 1990, 253:209-211.
92. Suzuki K, Miyakoshi N, Tsuchida T, Kasukawa Y, Sato K, Itoi E. Effects of combined treatment of insulin and human parathyroid hormone(1-34) on cancellous bone mass and structure in streptozotocin-induced diabetic rats. Bone 2003, 33:108-114.
93. Takeshita F, Murai K, Iyama S, Ayukawa Y, Suetsugu T. Uncontrolled diabetes hinders bone formation around titanium implants in rat tibiae. A light and fluorescence microscopy, and image processing study. Journal of Periodontology 1998, 69:314-320.
94. Terada M, Inaba M, Yano Y, Hasuma T, Nishizawa Y, Morii H, Otani S. Growth-inhibitory effect of a high glucose concentration on osteoblast-like cells. Bone 1998, 22:17-23.
95. Thaller SR, Lee TJ, Armstrong M, Tesluk H, Stern JS. Effect of insulin-like growth factor type 1 on critical-size defects in diabetic rats. Journal of Craniofacial Surgery 1995, 6:218-223.
96. Thrailkill KM, Lumpkin CK, Bunn RC, Kemp SF, Fowlkes JL. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. American Journal of Physiology, Endocrinology and Metabolism 2005, 289:E735-E745.
97. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20:1183-1197. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
98. Tisdel CL, Marcus RE, Heiple KG. Triple arthrodesis for diabetic peritalar neuroarthropathy. Foot Ankle International 1995, 16:332-338.
99. Topping RE, Bolander ME, Balian G. Type X collagen in fracture callus and the effects of experimental diabetes. Clinical Orthopaedics and Related Research 1994, 308:220-228.
100. Tyndall WA, Beam HA, Zarro C, O'Connor JP, Lin SS. Decreased platelet derived growth factor expression during fracture healing in diabetic animals. Clinical Orthopaedics and Related Research 2003, 408:319-330.
101. Umpierrez GE, Zlatev T, Spanheimer RG. Correction of altered collagen metabolism in diabetic animals with insulin therapy. Matrix 1989, 9:336-342.
102. Valerio G, del Puente A, Esposito-del Puente A, Buono P, Mozzillo E, Franzese A. The lumbar bone mineral density is affected by long-term poor metabolic control in adolescents with type 1 diabetes mellitus. Hormone Research 2002, 58:266-272.
103. Verhaeghe J, Suiker AM, Einhorn TA, Geusens P, Visser WJ, Van Herck E, Van Bree R, Magitsky S, Bouillon R. Brittle bones in spontaneously diabetic female rats cannot be predicted by bone mineral measurements: studies in diabetic and ovariectomized rats. Journal of Bone and Mineral Research 1994, 9:1657-1667.
104. Verhaeghe J, Van Herck E, Van Bree R, Moermans K, Bouillon R. Decreased osteoblast activity in spontaneously diabetic rats. In vivo studies on the pathogenesis. Endocrine 1997, 7:165-175.
105. Verhaeghe J, Van Herck E, Visser WJ, Suiker AM, Thomasset M, Einhorn TA, Faierman E, Bouillon R. Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis. Diabetes 1990, 39:477-482.
106. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis. Osteoporosis International 2007, 18:427-444.
107. Weiss RE, Reddi AH. Influence of experimental diabetes and insulin on matrix induced cartilage and bone differentiation. American Journal of Physiology 1980, 238:E200-E207.
108. Zayzafoon M, Botolin S, McCabe LR. P38 and activating transcription factor-2 involvement in osteoblast osmotic response to elevated extracellular glucose. The Journal of Biological Chemistry 2002, 277:37212-37218.